Milestone Pharmaceuticals Inc. announced the appointment of Francis Plat, MD, FAHA, as Chief Medical Officer of the company. Dr. Plat is a board-certified cardiologist with extensive experience in cardiovascular drug development. Most recently, Dr. Plat was Vice President and Therapeutic Area Head, Atherosclerosis and Cardiovascular at Merck Research Laboratories.